Plasmodium: Drug discovery and development - An industrial perspective

Experimental Parasitology

Volumn 87, Issue 3, 1997, Pages 293-304

  Ridley, Robert G ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT;

COST; DRUG DEVELOPMENT; HUMAN; INDUSTRY; MALARIA; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REGISTRATION; REVIEW;

EID: 0031282305     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1997.4230     Document Type: Article

References (52)

1. Anderson, S. L., Berman, J., Kuschner, R., Wesche, D., Magill, A., Wellde, B., Schneider, I., Dunne, M., and Schuster, B. G. 1995. Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers. Ann. Intern. Med. 123, 771-773.
2. Berger, B. J., Paciorkowski, A., Suskin, M., Dai, W. W., Cerami, A., and Ulrich, P. 1996. Antimalarial activity of novel arylene bis(methylketone) compounds. J. Infect. Dis. 174, 659-662.
3. Bohle, S. D., Dinnebier, R. E., Madsen, S. K., and Stephens, P. W. 1996. Characterization of the products of the heme detoxification pathway in malarial late trophozoites by X-ray diffraction. J. Biol. Chem. 272, 713-716.
4. Butler, D. 1997. Malaria meeting charts rocky road ahead. Nature 388, 219.
5. Canfield, C. J., Milhous, W. K., Ager, A. L., Rossan, R. N., Sweeney, T. R., Lewis, N. J., and Jacobus, D. P. 1993. PS-15: A potent, orally active antimalarial from a new class of folic acid antagonist. Am. J. Trop. Med. Hyg. 49, 121-126.
6. Cooper, R. D., Milhous, W. K., and Rieckmann, K. H. 1994. The efficacy of WR238605 against the blood stages of a chloroquine resistant strain of Plasmodium vivax. Trans. Roy. Soc. Trop. Med. Hyg. 88, 691-692.
7. Crabb, B. S., Cooke, B. M., Reeder, J. C., Waller, R. F., Caruana, S. R., Davern, K. M., Wickham, M. E., Brown, G. V., Coppel, R. L., and Cowman, A. F. 1997. Targeted gene disruption shows that knobs enable malaria-infected red cells to cytoadhere under physiological shear stress. Cell 89, 287-296.
8. Cumming, J. N., Ploypradith, P., and Posner, G. H. 1996. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action. Adv. Pharmacol. 37, 253-296.
9. Davidson, D. E., Jr. 1994. Role of arteether in the treatment of malaria and plans for further development. Trans. R. Soc. Trop. Med. Hyg. 88(Suppl. 1), S51-S52.
10. De, D., Krogstad, F. M., Cogswell, F. B., and Krogstad, D. J. 1996. Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 55, 579-583.
11. Dorn, A., Stoffel, H., Matile, H., Bubendorf, A., and Ridley, R. G. 1995. Malarial haemozoin/β-haematin supports haem polymerization in the absence of protein. Nature 374, 269-271.
12. Drews, J., and Ryser, S. 1997. Pharmaceutical innovation between scientific opportunities and economic constraints. Drug Discovery Today 2, 365-372.
13. Dunn, C. R., Banfield, M. J., Barker, J. J., Higham, C. W., Moreton, K. M., Turgut Balik, D., Brady, R. L., and Holbrook, J. J. 1996. The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for antimalarial drugs. Nat. Struct. Biol. 3, 912-915.
14. Egan, T. J., Ross, D. C., and Adams, P. A. 1996. The mechanism of action of quinolines and related antimalarial drugs. South African J. Science 92, 11-14.
15. Fitch, C. D., Chevli, R., Banyal, H. S., Phillips, G., Pfaller, M. A., and Krogstad, D. J. 1982. Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex. Antimicrob. Agents. Chemother. 21, 819-822.
16. Francis, S. E., Gluzman, I. Y., Oksman, A., Knickerbocker, A., Mueller, R., Bryant, M. L., Sherman, D. R., Russel, D. G., and Goldberg, D. E. 1994. Molecular characterisation and inhibition of a Plasmodium falciparum aspartic haemoglobinase. EMBO J. 13, 306-317.
17. Fry, M., and Beesley, J. E. 1991. Mitochondria of mammalian Plasmodium spp. Parasitology 102, 17-26.
18. Fu, S., and Xiao, S.-H. 1991. Pyronaridine: A new antimalarial drug. Parasitology Today 7, 310-313.
19. Gassis, S., and Rathod, P. K. 1996. Frequency of drug resistance in Plasmodium falciparum: A non-synergistic combination of 5-fluoroorotate and atovaquone suppresses in vitro resistance. Antimicrob. Agents Chemother. 40, 914-919.
20. Gutteridge, W. E., Dave, D., and Richards, W. H. G. 1979. Conversion of dihydroorotate to orotate in parasitic protozoa. Biochim. Biophys. Acta 582, 390-401.
21. Hofheinz, W., Burgin, H., Gocke, E., Jaquet, C., Masciadri, R., Schmid, G., Stohler, H., and Urwyler, H. 1994. Ro 42-1611 (arteflene), a new effective antimalarial: Chemical structure and biological activity. Trop. Med. Parasitol. 45, 261-265.
22. Hudson, A. T. 1993. Atovaquone - A novel broad-spectrum anti-infective drug. Parasitology Today 9, 66-68.
23. Koehler, S., Delwiche, C. F., Denny, P. W., Tilney, L. G., Webster, P., Wilson, R. J. M., Palmer, J. D., and Roos, D. S. 1997. A plastid of probable green algal origin in apicomplexan parasites. Science 275, 1485-1489.
24. Looareesuwan, S., Viravan, C., Webster, H. K., Kyle, D. E., Hutchinson, D. B., and Canfield, C. J. 1996. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am. J. Trop. Med. Hyg. 54, 62-66.
25. McFadden, G. I., Reith, M. E., Munholland, J., and Lang-Unasch, N. 1996. Plastid in human parasites. Nature 381, 482.
26. Menard, R., Sultan, A. A., Cortes, C., Altszuler, R., van Dijk, M. R., Janse, C. J., Waters, A. P., Nussenzweig, R. S., and Nussenzweig, V. 1997. Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes. Nature 385, 336-340.
27. Meshnick, S. R., Taylor, T. E., and Kamchonwongpaisan, S. 1996. Artemisinin and antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol. Rev. 60, 301-315.
28. Moon, R. P., Tyas, L., Certa, U., Rupp, K., Bur, D., Jaquet, C., Matile, H., Loetscher, H., Grueninger-Leitch, F., Kay, J., Dunn, B. M., Berry, C., and Ridley, R. G. 1997. Expression and characterization of plasmepsin I from Plasmodium falciparum. Eur. J. Biochem. 552-560.
29. Nateghpour, M., Ward, S. A., and Howells, R. E. 1993. Development of halofantrine resistance and determination of cross-resistance patterns in Plasmodium falciparum. Antimicrob. Agents Chemother. 37, 2337-2343.
30. Ohrt, C., Richie, T. L., Widjaja, H., Shanks, G. D., Fitriadi, J., Fryauff, D. J., Handschin, J., Tang, D., Sandajaja, B., Tjitra, E., Hadiarso, L., Watt, G., and Wignall, F. S. 1997. Mefloquine compared to doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 126, 963-972.
31. Olliaro, P. L., and Goldberg, D. E. 1995. The plasmodium digestive vacuole: Metabolic headquarters and choice drug target. Parasitol. Today 11, 294-297.
32. Olliaro, P., and Wirth, D. 1997. New targets for antimalarial drug discovery. J. Pharm. Pharmacol. 49(Suppl. 2), 29-33.
33. O'Neill, P. M., Willcock, D. J., Hawley, S. R., Bray, P. G., Storr, R. C., Ward, S. A., and Park, B. K. 1997. Synthesis, antimalarial activity, and molecular modeling of tebuquine analogues. J. Med. Chem. 40, 437-448.
34. Pandey, A. V., and Tekwani, B. L. 1997. Depolymerization of malarial hemozoin: A novel reaction initiated by blood schizonticidal antimalarials. FEBS Lett. 402, 236-240.
35. Peters, W., Robinson, B. L., Tovey, G., Rossier, J. C., and Jefford, C. W. 1993. The chemotherapy of rodent malaria. L. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. 3. Observations on 'Fenozan-50F,' a difluorinated 3,3′-spirocyclopentane 1,2,4-trioxane. Ann. Trop. Med. Parasitol. 87, 111-123.
36. Posner, G. H. 1997. Antimalarial endoperoxides that are potent and easily synthesized. J. Pharm. Pharmacol. 49, 55-57.
37. Radloff, P. D., Philipps, J., Nkeyi, M., Sturchler, D., Mittelholzer, M. L., and Kremsner, P. G. 1996. Arteflene compared with mefloquine for treating Plasmodium falciparum malaria in children. Am. J. Trop. Med. Hyg. 55, 259-262.
38. Ridley, R. G., Hofheinz, W., Matile, H., Jaquet, C., Dorn, A., Masciadri, M., Jolidon, S., Richter, W. F., Guenzi, A., Girometta, M.-A., Urwyler, H., Huber, W., Thaithong, S., and Peters, W. 1996. 4-Aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 40, 1846-1854.
39. Ridley, R. G. 1997. Haemoglobin degradation and haem polymerisation as antimalarial drug targets. J. Pharm. Pharmacol. 49(Suppl. 2), 43-48.
40. 2bis(7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: Comparison of two stereoisomers and detailed evaluation of the S,S-enantiomer, Ro 47-7737. Antimicrob. Agents Chemother. 41, 677-686.
41. Ridley, R. G., Dorn, A., Vippagunta, S. R., and Vennerstrom, J. L. 1997b. Haematin (haem) polymerisation and its inhibition by quinoline antimalarials. Ann. Trop. Med. 91, 559-566.
42. Rosenthal, P. J., Olsen, J. E., Lee, G. K., Palmer, J. T., Klaus, J. L., and Rasnick, D. 1996. Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors. Antimicrob. Agents Chemother. 40, 1600-1603.
43. Slater, A. F. G., Swiggard, W. J., Orton, B. R., Flitter, W. D., Goldberg, D. E., Cerami, A., and Henderson, G. B. 1991. An iron-carboxylate bond links the heme units of malaria pigment. Proc. Natl. Acad. Sci. USA 88, 325-329.
44. Slater, A. F. G. 1993. Chloroquine: Mechanism of drug action and resistance to Plasmodium falciparum. Pharmac. Ther. 57, 203-235.
45. Sullivan, D. J., Jr., Gluzman, I. Y., Russel, D. G., and Goldberg, D. E. 1996. On the molecular mechanism of chloroquine's antimalarial action. Proc. Natl. Acad. Sci. USA 93, 11865-11870.
46. van Es, H. G. G., Skamene, E., and Schurr, E. 1993. Chemotherapy against malaria: A battle against the odds? Clin. Invest. Med. 16, 285-293.
47. Vennerstrom, J. L., Ellis, W. Y., Ager, A. L. Andersen, S. L., Gerena, L., and Milhous, W. K. 1992. Bisquinolines. I. N,N-Bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine resistant malaria. J. Med. Chem. 35, 2129-2134.
48. Walter, R. D. 1991. Folate metabolism as a target for chemotherapy of malaria. In "Biochemical Protozoology" (G. Coombs and M. North, Eds.), pp. 560-568. Taylor and Francis, London.
49. Warhurst, D. C. 1997. Drug-resistant malaria: Laboratory and field investigations. J. Pharm. Pharmacol. 49(Suppl. 2), 3-7.
50. White, N. J. 1992. Antimalarial drug resistance: The pace quickens. J. Antimicrob. Chemother. 30, 571-585.
51. Wilson, R. J. M., Denny, P. W., Preiser, P. R., Rangachari, K., Roberts, K., Roy, A., Whyte, A., Strath, M., Moore, D. J., Moore, P. W., and Williamson, D. H. 1996. Complete gene map of the plastid-like DNA of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 261, 155-172.
52. Wu, Y., Kirkman, L. A., and Wellems, T. E. 1996. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. Proc. Natl. Acad. Sci. USA 93, 1130-1134.